HomeCompareNGPHF vs MRK

NGPHF vs MRK: Dividend Comparison 2026

NGPHF yields 1572.20% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NGPHF wins by $1077741067.88M in total portfolio value
10 years
NGPHF
NGPHF
● Live price
1572.20%
Share price
$0.13
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1077741067.94M
Annual income
$957,889,321,796,134.40
Full NGPHF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — NGPHF vs MRK

📍 NGPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNGPHFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NGPHF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NGPHF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NGPHF
Annual income on $10K today (after 15% tax)
$133,637.29/yr
After 10yr DRIP, annual income (after tax)
$814,205,923,526,714.20/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, NGPHF beats the other by $814,205,923,518,117.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NGPHF + MRK for your $10,000?

NGPHF: 50%MRK: 50%
100% MRK50/50100% NGPHF
Portfolio after 10yr
$538870534.00M
Annual income
$478,944,660,903,124.06/yr
Blended yield
88.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NGPHF
No analyst data
Altman Z
-3.6
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NGPHF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNGPHFMRK
Forward yield1572.20%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1077741067.94M$57.7K
Annual income after 10y$957,889,321,796,134.40$10,113.78
Total dividends collected$1069055835.56M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NGPHF vs MRK ($10,000, DRIP)

YearNGPHF PortfolioNGPHF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$167,920$157,220.34$11,213$373.04+$156.7KNGPHF
2$2,647,011$2,467,335.92$12,667$512.06+$2.63MNGPHF
3$39,181,671$36,349,369.54$14,439$708.14+$39.17MNGPHF
4$544,776,598$502,852,210.29$16,640$988.16+$544.76MNGPHF
5$7,117,105,732$6,534,194,771.40$19,432$1,394.07+$7117.09MNGPHF
6$87,395,163,592$79,779,860,459.05$23,057$1,992.90+$87395.14MNGPHF
7$1,009,086,878,318$915,574,053,274.98$27,889$2,894.79+$1009086.85MNGPHF
8$10,959,584,496,028$9,879,861,536,227.98$34,518$4,286.29+$10959584.46MNGPHF
9$112,010,977,703,627$100,284,222,292,876.12$43,912$6,494.35+$112010977.66MNGPHF
10$1,077,741,067,939,015$957,889,321,796,134.40$57,714$10,113.78+$1077741067.88MNGPHF

NGPHF vs MRK: Complete Analysis 2026

NGPHFStock

Northern Graphite Corporation explores for and develops graphite properties in Canada. The company's principal asset is the Bissett Creek graphite project located in southern Canada, which comprises Ontario mining lease number 109550 covering 565 hectares; and Ontario mining lease number 109335 covering 1,938 hectares. It also holds interest in the Mousseau West graphite project located in Quebec; and explores for nickel-copper-cobalt properties. The company was formerly known as Industrial Minerals Canada Inc. and changed its name to Northern Graphite Corporation in March 2010. Northern Graphite Corporation was incorporated in 2002 and is headquartered in Ottawa, Canada.

Full NGPHF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NGPHF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NGPHF vs SCHDNGPHF vs JEPINGPHF vs ONGPHF vs KONGPHF vs MAINNGPHF vs JNJNGPHF vs ABBVNGPHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.